Huang Doudou, Jiang Yun, Chen Wansheng, Yao Fengyan, Huang Guanghui, Sun Lianna
Department of Identification of traditional Chinese Medicine, School of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Science, University of Macau, Macau, PR China.
J Ethnopharmacol. 2015 Apr 2;163:256-63. doi: 10.1016/j.jep.2015.01.014. Epub 2015 Jan 22.
Penthorum chinense Pursh has a long history of use as a health food and folk medicine to alleviate "heat"-associated disorders, promote circulation and diuresis, and to treat liver problems, and to protect the spleen. In this study we provide experimental evidence for the clinical use of Penthorum chinense in the treatment of diabetes mellitus. The aim of the study was to investigate the hypoglycemic effects of extracts and active constituents from Penthorum chinense.
High fat diet and STZ (35mg/kg) induced diabetic rats were administered with Penthorum chinense extract at graded oral doses (150 and 300mg/kg/day, ig.) for 2 weeks. A range of parameters, including blood glucose and lipid, serum insulin, glucose tolerance, were tested to evaluate its anti-hyperglycemic effects. Moreover, oral starch tolerance test (OSTT) was performed to test the level of postprandial glucose after administrating Penthorum chinense extract. In vitro study, the Penthorum chinense extracts and purified Penthorum chinense polyphenols were tested for α-amylase inhibitory activity. The polyphenols were determined by UPLC-Q-TOF mass spectrometry and NMR.
The Penthorum chinense extract possessed anti-hyperglycemic activities as shown by the decreased serum levels of glycosylated hemoglobulin A1C (HbA1c), triglyceride(TG), total cholesterol (TC), and low density lipoprotein-cholesterol (LDL-C), as well as increased serum levels of high density lipoprotein-cholesterol (HDL-C) and insulin. Penthorum chinense extract also improved the oral glucose tolerance test (OGTT) to a certain degree. Moreover, the OSTT study showed that in diabetic rats, the extract (600mg/kg) caused a significant hypoglycemic effect with a blood glucose reduction of 42% at 60min. To identify the active constituents, three polyphenols, pinocembrin-7-O-[4″,6″-hexahydroxydiphenoyl]-β-d-glucose (1), pinocembrin-7-O-[3″-O-galloyl-4″, 6″-hexahydroxydiphenoyl]-β- d-glucose (2), and thonningianin A (3) were isolated from Penthorum chinense. Compounds 1-3 moderately inhibited α-amylase activity, with IC50 values of 0.14, 0.03, and 0.08µmol/ml, respectively.
The folk medicinal plant, Penthorum chinense produced a moderated anti-hyperglycemic effect on STZ-induced diabetic rats and starch induced postprandial hyperglycemic mice.
赶黄草作为一种保健食品和民间药物,用于缓解“热”相关疾病、促进血液循环和利尿、治疗肝脏问题以及保护脾脏,已有悠久的历史。在本研究中,我们为赶黄草治疗糖尿病的临床应用提供了实验证据。本研究的目的是研究赶黄草提取物及活性成分的降血糖作用。
采用高脂饮食和链脲佐菌素(35mg/kg)诱导糖尿病大鼠,以不同口服剂量(150和300mg/kg/天,灌胃)给予赶黄草提取物,持续2周。检测一系列参数,包括血糖、血脂、血清胰岛素、葡萄糖耐量,以评估其降血糖作用。此外,进行口服淀粉耐量试验(OSTT),以检测给予赶黄草提取物后的餐后血糖水平。在体外研究中,检测赶黄草提取物和纯化的赶黄草多酚对α-淀粉酶的抑制活性。通过超高效液相色谱-四极杆飞行时间质谱联用仪和核磁共振对多酚进行测定。
赶黄草提取物具有降血糖活性,表现为糖化血红蛋白A1C(HbA1c)、甘油三酯(TG)、总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)的血清水平降低,以及高密度脂蛋白胆固醇(HDL-C)和胰岛素的血清水平升高。赶黄草提取物还在一定程度上改善了口服葡萄糖耐量试验(OGTT)。此外,OSTT研究表明,在糖尿病大鼠中,提取物(600mg/kg)具有显著的降血糖作用,60分钟时血糖降低42%。为鉴定活性成分,从赶黄草中分离出三种多酚,分别为松属素-7-O-[4″,6″-六羟基二苯甲酰基]-β-D-葡萄糖(1)、松属素-7-O-[3″-O-没食子酰基-4″,6″-六羟基二苯甲酰基]-β-D-葡萄糖(2)和托宁宁A(3)。化合物1-3对α-淀粉酶活性有中度抑制作用,IC50值分别为0.14、0.03和0.08µmol/ml。
民间药用植物赶黄草对链脲佐菌素诱导的糖尿病大鼠和淀粉诱导的餐后高血糖小鼠具有适度的降血糖作用。